1. Algorithm for management of attention deficit/hyperactivity disorder (ADHD). Treat predominant disorder first, reassess, and consider alternative or adjunct medications for optimal symptom control. (DEX, dextroamphetamine; DMPH, dexmethylphenidate; MPH, methylphenidate; MXA, mixed amphetamine salts; TCA, tricyclic antidepressant.) (Data from Dopheide JA, Pliszka SR. Attention deficit hyperactivity disorder: An update. Pharmacotherapy 2009;29(6):656–679; Pliszka SR, Bernet W, Bukstein O, et al, for the American Academy of Child and Adolescent Psychiatry Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894–921; Pliszka SR, Crismon ML, Hughes CW, et al. The Texas Children's Medication Algorithm project: Revision of the algorithm for pharmacotherapy of childhood attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2006;45(6):642–657; Kowatch RA, DelBello MP. Pediatric bipolar disorder: Emerging diagnostic and treatment approaches. Child Adolesc Psych Clin N Am 2006;15:73–108; Dopheide JA. Recognizing and treating depression in children and adolescents. Am J Health Syst Pharm 2006;63:233–243; Kenny C, Kuo SH, Jimenez-Shahed J. Tourette's syndrome. Am Fam Physician 2008;77(5):651–660; and Muller-Vahl JT. The treatment of Tourette's syndrome: Current opinions. Expert Opin Pharmacother 2002;3:899–914.)
Source: Chapter 72. Childhood Disorders, Pharmacotherapy: A Pathophysiologic Approach, 8e
Citation: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L. Pharmacotherapy: A Pathophysiologic Approach, 8e; 2011 Available at: Accessed: October 25, 2017
Copyright © 2017 McGraw-Hill Education. All rights reserved